Dyno Therapeutics logo

Dyno Therapeutics Inc.

Biotechnology

Dyno Therapeutics Stock

Dyno Therapeutics is developing an AI-powered biotechnology platform to create novel gene therapies. Its technology combines next-generation DNA synthesis, AAV capsid engineering, and machine learning to optimize gene delivery vectors, enabling more effective and safer gene therapies.

For more Dyno Therapeutics stock information, or to buy or sell private shares, sign up for a MicroVentures account.

Management Team

Eric Kelsic Co-Founder & Chief Executive Officer
Adrian Veres Co-Founder & Chief Scientific Officer
Tomas Bjorklun Co-Founder & Scientific Advisor
George Church Co-Founder & Scientific Advisor
Alan Crane Co-Founder & Chairman

Funding Information